tiprankstipranks
Trending News
More News >
Polygiene AB (SE:POLYG)
:POLYG
Advertisement

Polygiene AB (POLYG) AI Stock Analysis

Compare
0 Followers

Top Page

SE:POLYG

Polygiene AB

(Berlin:POLYG)

Rating:43Neutral
Price Target:
kr9.50
▼(-2.06% Downside)
Polygiene AB's overall stock score is primarily impacted by its financial performance and technical analysis. The company faces significant financial challenges, including negative profitability and declining revenue growth. Technical indicators further suggest bearish momentum. Valuation concerns are also present, with a negative P/E ratio and modest dividend yield.

Polygiene AB (POLYG) vs. iShares MSCI Sweden ETF (EWD)

Polygiene AB Business Overview & Revenue Model

Company DescriptionPolygiene Group AB develops, manufactures, and sells odor control and stay fresh solutions for clothes, sports equipment, textiles, and other materials in the Middle East, Africa, the Asia Pacific, the Americas, Europe, and internationally. It serves partners in the categories of sports and outdoor, fashion and lifestyle, workwear, hospitality, home and pets, healthcare, water, industrial, and paper and packaging. The company offers its products under the Polygiene brand. The company was formerly known as Polygiene AB (publ.) and changed its name to Polygiene Group AB in June 2022. Polygiene Group AB was founded in 2005 and is headquartered in Malmö, Sweden.
How the Company Makes MoneyPolygiene AB generates revenue primarily through licensing its technologies to manufacturers in the textile and material industries. The company partners with brands and manufacturers, allowing them to integrate Polygiene's antimicrobial and odor control solutions into their products. These partnerships typically involve a licensing fee or royalty based on the volume of treated materials. Additionally, Polygiene may engage in direct sales of its solutions to manufacturers and offer consulting services for technology integration. Strategic partnerships with key industry players and the growing demand for sustainable and hygienic solutions contribute significantly to the company's earnings.

Polygiene AB Financial Statement Overview

Summary
Polygiene AB shows strong revenue growth and operational efficiency but faces profitability challenges with negative net income margins. The balance sheet is stable with low leverage and high equity financing, while cash flow management is robust despite profitability issues impacting cash flow ratios.
Income Statement
65
Positive
Polygiene AB's income statement shows a mixed performance. The TTM gross profit margin is approximately 54.35%, indicating effective cost management. However, the TTM net profit margin is negative at -5.02%, reflecting recent net losses. Despite this, the company has shown a positive revenue growth trajectory from 2023 to 2024 with a rate of 38.25%. The EBIT and EBITDA margins also indicate operational efficiency, though profitability remains a challenge.
Balance Sheet
70
Positive
The balance sheet of Polygiene AB is relatively robust with a low debt-to-equity ratio of 0.008, suggesting low leverage. The equity ratio of 91.31% indicates strong equity financing, which enhances financial stability. However, a declining total asset base poses a potential risk for future growth. Return on equity is not available due to negative net income in some periods, highlighting profitability challenges.
Cash Flow
68
Positive
Polygiene AB's cash flow statement exhibits strong operational cash flows with an operating cash flow to net income ratio of 2.06 in TTM, indicating good cash generation relative to net income. The free cash flow has increased by 61.14% from 2023 to 2024, showing improved cash management. However, the free cash flow to net income ratio is negative due to net losses, suggesting profitability issues affecting cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue166.40M156.95M113.54M173.56M181.61M83.93M
Gross Profit111.31M103.78M77.16M114.57M115.24M56.53M
EBITDA13.81M18.80M-305.61M19.10M43.99M701.00K
Net Income-10.89M16.83M-321.95M8.36M32.83M-1.74M
Balance Sheet
Total Assets320.00M350.84M313.78M621.90M550.69M57.64M
Cash, Cash Equivalents and Short-Term Investments47.39M68.59M44.15M48.06M52.40M4.33M
Total Debt3.27M2.63M3.89M1.64M2.40M1.66M
Total Liabilities25.35M31.23M22.53M29.34M31.54M30.16M
Stockholders Equity294.65M319.61M291.25M592.56M519.15M27.48M
Cash Flow
Free Cash Flow3.37M22.75M-4.27M-50.64M34.15M1.03M
Operating Cash Flow5.05M24.34M3.79M-1.54M37.60M2.92M
Investing Cash Flow-2.05M-1.59M-9.42M-52.11M-407.47M-4.04M
Financing Cash Flow-6.58M-1.38M1.95M47.50M416.27M694.00K

Polygiene AB Technical Analysis

Technical Analysis Sentiment
Negative
Last Price9.70
Price Trends
50DMA
12.00
Negative
100DMA
11.29
Negative
200DMA
11.71
Negative
Market Momentum
MACD
-0.73
Positive
RSI
33.54
Neutral
STOCH
29.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:POLYG, the sentiment is Negative. The current price of 9.7 is below the 20-day moving average (MA) of 10.87, below the 50-day MA of 12.00, and below the 200-day MA of 11.71, indicating a bearish trend. The MACD of -0.73 indicates Positive momentum. The RSI at 33.54 is Neutral, neither overbought nor oversold. The STOCH value of 29.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:POLYG.

Polygiene AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$20.37B12.70-7.34%3.15%2.86%-10.22%
43
Neutral
kr354.31M28.16-5.49%1.44%21.21%94.88%
€29.01M-7.20%
€2.68M-598.14%
€12.86M-42.76%
€12.72M-27.73%
€17.75M-74.60%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:POLYG
Polygiene AB
9.70
-0.66
-6.40%
DE:NC4
Nexam Chemical Holding AB
0.31
-0.08
-20.51%
DE:651
LifeClean International AB
0.01
-0.21
-95.45%
DE:284
Serstech AB
0.03
-0.09
-75.00%
DE:A6X
aXichem AB Class A
0.18
0.11
157.14%
DE:0CF
OrganoClick AB
0.13
-0.12
-48.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 06, 2025